Jaewon Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jaewon Kim has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Jong Seung Kim
Department of Chemistry Korea University Seoul South Korea
5 shared publications Byungkook Kim
Department of Chemistry, Korea University, Seoul, 02841, Korea
2 shared publications- Heemin Kang
Department of Materials Science and Engineering, Korea University, Seoul, Korea
2 shared publications Injun Lee
Department of Chemistry, Korea University, Seoul, Korea
2 shared publications- Jungryun Kim
Department of Chemistry Korea University Seoul South Korea
2 shared publications - Chan Gyu Yoon
Department of Chemistry, Korea University, Seoul, Korea
1 shared publication
Latest Publications
- 25 April 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (41) , 5443-5446
An AIE-based fluorescent probe to detect peroxynitrite levels in human serum and its cellular imaging
An AIE-based fluorescent probe was designed to evaluate peroxynitrite levels in complex biological samples. The newly synthesized hydrazone-conjugated probe fluoresces strongly in the presence of peroxynitrite. Clinically, the peroxynitrite levels can be measured in human serum and cellular mitochondria with an LOD of 6.5 nM by fluorescence imaging in vitro.
- 25 April 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (41) , 5443-5446
An AIE-based fluorescent probe to detect peroxynitrite levels in human serum and its cellular imaging
An AIE-based fluorescent probe was designed to evaluate peroxynitrite levels in complex biological samples. The newly synthesized hydrazone-conjugated probe fluoresces strongly in the presence of peroxynitrite. Clinically, the peroxynitrite levels can be measured in human serum and cellular mitochondria with an LOD of 6.5 nM by fluorescence imaging in vitro.
- Open Access
A panoramic perspective of recent progress in 2D and 3D covalent organic frameworks for drug delivery
The development of efficient drug delivery systems is essential for improving the efficacy and safety of cancer drugs, particularly for aggressive and difficult‐to‐treat cancers. Covalent organic frameworks (COFs) are emerging as innovative porous nanomaterials in drug delivery systems (DDS), due to their unique properties, including the metal‐free organic skeleton, predetermined structures and pore geometries, high porosity, large surface area, facile surface modification potential, and good biocompatibility. These characteristics make COFs excellent candidates for improving drug delivery by enhancing drug loading capacity and enabling precise encapsulation. This review emphasizes the importance of donor‐acceptor‐based COFs, which provide channels for charge transportation, and we also explore how the π‐conjugated skeleton of COFs enhances its long‐acting fluorescent properties and facilitates drug uptake via cell endocytosis. While this review primarily focuses on recent advancements in COF‐based targeted DDS, it also acknowledges the challenges posed by the diverse pore geometries in porous materials and discusses potential solutions. Further, it underlines the potential of developing future drug carriers that can successfully and specifically target cancer cells, improving treatment efficiency while reducing adverse side effects.
Open AccessA panoramic perspective of recent progress in 2D and 3D covalent organic frameworks for drug delivery
The development of efficient drug delivery systems is essential for improving the efficacy and safety of cancer drugs, particularly for aggressive and difficult‐to‐treat cancers. Covalent organic frameworks (COFs) are emerging as innovative porous nanomaterials in drug delivery systems (DDS), due to their unique properties, including the metal‐free organic skeleton, predetermined structures and pore geometries, high porosity, large surface area, facile surface modification potential, and good biocompatibility. These characteristics make COFs excellent candidates for improving drug delivery by enhancing drug loading capacity and enabling precise encapsulation. This review emphasizes the importance of donor‐acceptor‐based COFs, which provide channels for charge transportation, and we also explore how the π‐conjugated skeleton of COFs enhances its long‐acting fluorescent properties and facilitates drug uptake via cell endocytosis. While this review primarily focuses on recent advancements in COF‐based targeted DDS, it also acknowledges the challenges posed by the diverse pore geometries in porous materials and discusses potential solutions. Further, it underlines the potential of developing future drug carriers that can successfully and specifically target cancer cells, improving treatment efficiency while reducing adverse side effects.
- Top Cited Papers
- 29 August 2023
- Published by Springer Nature in Nature Reviews Materials
- Vol. 8 (11) , 710-725
In situ self-assembly for cancer therapy and imaging
- 29 August 2023
- Published by Springer Nature in Nature Reviews Materials
- Vol. 8 (11) , 710-725
Top Cited PapersIn situ self-assembly for cancer therapy and imaging
- Open Access
- 14 September 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 21, 358-380
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Nanomedicines for drug delivery and imaging-guided cancer therapy is a rapidly growing research area. The unique properties of nanomedicines have a massive potential in solving longstanding challenges of existing cancer drugs, such as poor localization at the tumor site, high drug doses and toxicity, recurrence, and poor immune response. However, inadequate biocompatibility restricts their potential in clinical translation. Therefore, advanced nanomaterials with high biocompatibility and enhanced therapeutic efficiency are highly desired to fast-track the clinical translation of nanomedicines. Intrinsic properties of nanoscale covalent organic frameworks (nCOFs), such as suitable size, modular pore geometry and porosity, and straightforward post-synthetic modification via simple organic transformations, make them incredibly attractive for future nanomedicines. The ability of COFs to disintegrate in a slightly acidic tumor microenvironment also gives them a competitive advantage in targeted delivery. This review summarizes recently published applications of COFs in drug delivery, photo-immuno therapy, sonodynamic therapy, photothermal therapy, chemotherapy, pyroptosis, and combination therapy. Herein we mainly focused on modifications of COFs to enhance their biocompatibility, efficacy and potential clinical translation. This review will provide the fundamental knowledge in designing biocompatible nCOFs-based nanomedicines and will help in the rapid development of cancer drug carriers and theranostics.
- 14 September 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 21, 358-380
Open AccessCovalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Nanomedicines for drug delivery and imaging-guided cancer therapy is a rapidly growing research area. The unique properties of nanomedicines have a massive potential in solving longstanding challenges of existing cancer drugs, such as poor localization at the tumor site, high drug doses and toxicity, recurrence, and poor immune response. However, inadequate biocompatibility restricts their potential in clinical translation. Therefore, advanced nanomaterials with high biocompatibility and enhanced therapeutic efficiency are highly desired to fast-track the clinical translation of nanomedicines. Intrinsic properties of nanoscale covalent organic frameworks (nCOFs), such as suitable size, modular pore geometry and porosity, and straightforward post-synthetic modification via simple organic transformations, make them incredibly attractive for future nanomedicines. The ability of COFs to disintegrate in a slightly acidic tumor microenvironment also gives them a competitive advantage in targeted delivery. This review summarizes recently published applications of COFs in drug delivery, photo-immuno therapy, sonodynamic therapy, photothermal therapy, chemotherapy, pyroptosis, and combination therapy. Herein we mainly focused on modifications of COFs to enhance their biocompatibility, efficacy and potential clinical translation. This review will provide the fundamental knowledge in designing biocompatible nCOFs-based nanomedicines and will help in the rapid development of cancer drug carriers and theranostics.
- Top Cited Papers
- 7 September 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 51 (19) , 8201-8215
Cancer therapeutics based on diverse energy sources
Light has been utilized for cancer treatment owing to its advantages. Low penetration depth of light restricts its application in cancer treatment. To overcome the drawback, various treatments based on each energy sources have been developed.
- 7 September 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 51 (19) , 8201-8215
Top Cited PapersCancer therapeutics based on diverse energy sources
Light has been utilized for cancer treatment owing to its advantages. Low penetration depth of light restricts its application in cancer treatment. To overcome the drawback, various treatments based on each energy sources have been developed.
- 26 April 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1210, 339879
pH-guided fluorescent sensing probe for the discriminative detection of Cl− and Br− in human serum
- 26 April 2022
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1210, 339879
pH-guided fluorescent sensing probe for the discriminative detection of Cl− and Br− in human serum